Summary Little is known of the mechanisms by which dietary fatty acids (FAs) may affect normal epithelial cell physiology and thereby directly or indirectly influence tumour incidence and progression. In this study, we have used normal human urothelial cell cultures to investigate whether FAs may modify proliferation of normal human epithelial cells in vitro. FAs were presented as albumin complexes in serum-free medium and the effects on proliferation over a concentration range of 1-100 gM were assayed by thymidine incorporation.
The past 30 years have seen significant changes in the western dietary intake of fatty acids (FAs). To an extent this change has been driven by indications that an increase in the ratio of polyunsaturated (PUFA) to saturated FAs in the diet may reduce coronary disease. Evidence that the dietary intake of FAs may also affect cancer incidence is largely epidemiological but implicates a high fat intake with increased risk of colon and breast cancer (reviewed by Narisawa et al., 1994; Reddy, 1994) . There is further epidemiological evidence to suggest that the low incidence of breast and colon cancer seen among traditional Mediterranean, Inuit or Japanese populations may be related respectively to diets high in monounsaturated oleic acid or fish-based diets high in polyunsaturated n-3 FAs (reviewed in Narisawa et al., 1994; Reddy, 1994) . Despite inherent problems associated with human controlled feeding studies and in extrapolating human diets to animal models, these observations are finding some support in human trials (Dolecek and Granditis, 1991) and in rodent systems (reviewed in Kromhout, 1990; Narisawa et al., 1994) .
The mechanism(s) by which FAs may suppress or enhance tumour development are unclear. On the basis of animal studies, several hypotheses have been put forward to explain why polyunsaturated n-3 FAs might be tumour suppressive, including reduced sensitivity to tumour promoters as a consequence of changes in membrane lipid composition (Narisawa et al., 1991) . It has also been shown that a n-3 PUFA-rich diet can reduce the proliferation rate of normal colonic crypt epithelial cells (Anti et al., 1992; Bartram et al., 1993; Pell et al., 1994) . As reduced normal cell proliferation may confer protection against the development of cancer (Preston-Martin et al., 1990) , this raises the intriguing possibility that PUFAs may be inhibitory to all rapidly proliferating epithelial cells, rather than just malignantly transformed carcinoma cells.
In order to address this question, we have taken advantage of our system for the in vitro propagation of normal human epithelial cells of urinary tract origins. We have shown previously that normal urothelial cells can be isolated from urinary bladder, ureter and renal pelvis and maintained in a highly proliferative state in serum free culture (Hutton et al., 1993; Southgate et al., 1994) . Urothelial cells are the precursors of transitional cell carcinoma (TCC), the incidence of which generally mirrors the incidence of breast and colon cancer (Whelan et al., 1990; Parkin et al., 1993) and for which exogenous risk factors have been identified as important. Thus, we have used the urothelial model to study the effects on normal epithelial cell proliferation of physiologically presented saturated, monounsaturated (MUFA) and n-3 and n-6 polyunsaturated FAs of 18-22 carbon chain length.
Materials and methods
Normal urothelial cell culture Urothelial tissues were obtained from the upper and lower urinary tract of children undergoing open urological operations for non-malignant conditions. Using our previously described procedures (Southgate et al., 1994) , urothelial cell sheets were isolated from the stroma by overnight incubation at 4°C in Hanks' balanced salt solution containing 10 mM Hepes pH 7.6, 0.1% (w/v) EDTA and 20 kIU aprotinin. The urothelial cell sheets were disaggregated by incubation for 20 min in 100 U ml-' collagenase type IV (Sigma, Poole, UK) and the cells were seeded into 'Primaria' tissue culture flasks (Becton Dickinson, Cowley, UK) at a minimum density of 4 x 104 cells cm-2 in 'keratinocyte serum-free medium' (KSFM) containing recombinant epidermal growth factor and bovine pituitary extract at the manufacturer's recommended concentrations (Gibco BRL, Paisley, UK) and cholera toxin at 30 ng ml-'.
BSA (Sigma). Complexes were prepared with stearic acid (18:0), oleic acid (18:1 n-9), linoleic acid (18:2 n-6), vlinolenic acid (GLA; 18: 3 n-6), a-linolenic acid (ALA; 18: 3 n-3), eicosapentaenoic acid (EPA; 20: 5 n-3) and docosahexaenoic acid (DHA; 22:6 n-3), using a biphasic heptane base conjugation and separation technique (Spector et al., 1969) . All reactions and procedures were performed in the dark under an atmosphere of nitrogen in order to protect the FAs from oxidation and/or photodegradation. After conjugation, FA -BSA complexes were dialysed extensively against distilled water and lyophilised. BSA for control cultures was processed through a mock conjugation/separation protocol. The complexes were stored dehydrated and were freshly reconstituted in medium as required. The solutions were filter sterilised through 0.2 gm Acrodisc filters (Gelman Sciences, Northampton, UK) before use.
The FA-BSA complexes were analysed using a proprietary spectrophotomeric assay for non-esterified FA supplied by Randox Laboratories (Ardmore, Co. Antrim, Ireland). Analysis of the growth medium determined the baseline concentration of FA to be between 0.4 and 1.9 JgM. All cell culture experiments were performed using the BSA-complexed FA and the final BSA concentration of the medium (including the no FA control) was always adjusted to 10 mg ml-' using FA-free (mock-conjugated) BSA. A final series of experiments tested the effects of combinations of three or four FAs on cell proliferation. The total concentration of FA in each experiment was either 30 ,uM or 100 JgM (two independent cell lines each) and the ratios of FAs in each combination was based broadly on ratios of free unsaturated (stearic acid): mono-unsaturated (oleic acid): polyunsaturated n-6 (linoleic acid) and polyunsaturated n-3 (EPA) FA found either in the human circulation (Lentner, 1984) or based on ratios typical of 'traditional' Italian, Finnish, American, Japanese and vegetarian diets (Table I ) from studies of dietary fat intakes and plasma levels of free FA (Dougherty et al., 1987; Garton et al., 1992; Agren et al., 1995) . The other combinations were based on n-3-and n-6-rich diets from the work of Narisawa et al. (1991 and 1994 (Figure lc) . The most marked changes were noted with GLA (Figure ld) , whereas ALA showed only minor changes. All morphological changes were more marked at 100 gLM than 30 gM FA and were accompanied by a dose-dependent increase in cytoplasmic granularity. Staining of cell monolayers with Sudan IV demonstrated that the increase in granularity was owing to the accumulation of lipid inclusion bodies in the cytoplasm (Figure le -f) .
Analysis of cell morphology
The marked morphological changes were not accompanied by marked detachment of cells from the monolayer. Nuclei retained prominent nucleoli and there was no evidence of either nuclear pyknosis of apoptotic nuclear fragmentation in any cells, as judged by acridine orange or haematoxylin and eosin staining.
Effects of individual FAs on cell proliferation
Stearic acid had no effect on cell proliferation over a 1-100 gUM concentration range. The mono-unsaturated oleic acid showed a slight enhancement of thymidine incorporation at 10 giM concentration (P<0.001 by t-test), but at higher concentrations was growth suppressive (P<0.001, ANOVA), inhibiting thymidine uptake to approximately 60% of control at 100 ,UM oleic acid (Figure 2) . PUFAs at concentrations of up to 10 gM either had no effect (linoleic acid and GLA) relative to the albumin control, or showed a small enhancement of thymidine incorporation between 1 and 10 gM (ALA, EPA and DHA) . This mitogenic effect was significant by t-test (P<0.001), but not by the by t-test and ANOVA with Bonferroni correction). inhibitory effects of both PUFAs and reduced the growth inhibitory effects of both the n-3 and n-6 PUFAs to some extent, even when present as only 10% of the total FA (Figure 3) . By contrast, the inhibitory effects of linoleic acid and EPA were found to be additive, such that the total concentration of PUFA determined the degree of inhibition of thymidine incorporation (Figure 3 ).
Effect of multiple FA combinations on cell proliferation
Where the total FA concentration was limited to 30 g1M, there was a significant decrease in thymidine incorporation in FA concentrations in which PUFA was the major component(s) (> 70% of total). The effect was independent of whether the PUFA was predominantly in the form of n-3 or n-6 (Figure   4 ). At 100 gM total FA concentration, the inhibition of thymidine incorporation also became evident in the 'diet' mixture in which PUFA accounted for 50% of control. However, where the majority of the mixture was in the form of saturated or mono-unsaturated FA, there was no significant difference from the no FA control at either 30 or 100 gIM total FA (Figure 4) .
Discussion
There is a consensus in the literature that PUFAs inhibit the growth of carcinoma cells in vitro. However, it is less clear whether these effects relate to cell proliferation rate per se, or to a consequence of the malignant transformation process of epithelial cells. Although several studies have shown Table I ). Results al., 1986) or to an immortalised breast carcinoma-derived cell line (Grammatikos et al., 1994) as the 'non-cancerous' counterpart. Clearly, neither case can offer a true reflection of the effects of FAs on normal epithelial cell proliferation. Our study is one of the first to report on the in vitro effects of FAs on normal human adult epithelial cells and our observations suggest that there are marked similarities in the responses to FAs of normal proliferating epithelial cells compared with studies involving carcinoma-derived cell lines. This is in agreement with studies of the effects of dietary FAs on proliferation of normal cells in vivo, which have also demonstrated that diets high in PUFAs can be anti-mitotic for the normally rapidly proliferating epithelial cells in intestinal crypts (Anti et al., 1992; Bartram et al., 1993; Pell et al., 1994) .
We have used free (non-esterified) FAs in the form of albumin-bound complexes as this is the physiological mode of presentation to normal cells in vitro. This hinders comparison with other approaches, such as the use of FAs in ethanol solution (Rose and Connolly, 1990; DeKoch et al., 1994; Hatala et al., 1994; Sylvester et al., 1994; Maehle et al., 1995) . Nevertheless, almost all authors have reported that both n-3 and n-6 PUFAs inhibit growth of cells in vitro in an irreversible, dose-dependent manner. The one exception is the study of Sylvester et al. (1994) , which showed stearic acid to be growth inhibitory and n-6 arachidonic acid to be stimulatory in mouse mammary epithelial cells respectively. From our data and the observations of others, we suggest that epithelial cell sensitivity to the cytostatic effects of PUFAs may be a function of proliferative activity and hence is not necessarily related to malignant transformation. Although the urothelium is a very slow turnover epithelium in situ, it is capable of very rapid proliferation rates both during regeneration in vivo (Marceau, 1990) and when grown in vitro, where we have shown the doubling time to be in the order of 15 h (Southgate et al., 1994) . Hence, in studies where normal, immortalised or cancerous cell lines have been compared (Cantril et al., 1993; Grammatikos et al., 1994) , it was not clear whether there are underlying differences in proliferation rates which may account for differences in sensitivity to the cytostatic and cytotoxic effects of PUFAs.
It has been proposed that the differential effects of PUFAs on tumour cells may reflect decreased desaturase activity and hence an increased metabolic requirement for exogenous FAs (discussed by Grammatikos et al., 1994) . However, in normal peripheral blood lymphocytes, where dividing and nondividing cell populations can be compared, it has been shown that mitogenesis is accompanied by a rapid and sustained increase in the polyunsaturation of the plasma membrane (Shires et al., 1989 address the differential effects of n-3 and n-6 PUFAs on tumorigenesis, the data do suggest that n-6 PUFAs are more cytostatic to normal cells than n-3 PUFAs of an equivalent 18 carbon chain length. There was also a closer similarity in the dose-related response characteristics of normal urothelial cells to the 18C mono-unsaturated oleic and C18 n-3 ALA, than to either of the C18 n-6 PUFAs tested.
As noted above, the in vivo data would suggest that diets high in fish oils might protect against tumour development (Anti et al., 1992) and growth (Narisawa et al., 1994) and can inhibit normal epithelial cell proliferation in colonic crypts (Bartram et al., 1993; Pell et al., 1994) . Although the effects of fish oils have been attributed to the n-3 PUFAs, it must be remembered that fish oils typically contain less than 50% of n-3 PUFAs and it has been pointed out that care should be taken when attributing effects to single fatty acids when complex mixtures of oils are administered (Garton, 1992) . In our experiments with complex mixtures, effects attributable to PUFAs were only observed where the PUFAs contributed to more than 50% of the total fatty acids and were very much more pronounced at high FA concentrations. Our data suggest that PUFAs of both n-3 and n-6 types may be growth inhibitory and therefore any differential effects of n-3 vs n-6 PUFAs on cell growth in vivo might be attributable to additional factors.
In addition to a potential role in colon cancer prevention (Anti et al., 1992) , there is considerable interest in exploiting the dietary effects of n-3 PUFAs as an adjunct to conventional cancer therapy (reviewed by Das, 1990; Burns and Spector, 1994) . However, our findings advocate caution if the targets are proliferating rather than specific tumour cell populations, as such an approach would offer no advantage over other conventional chemotherapy or radiotherapy regimens. In this context, it is of interest that the PUFAs appeared to irreversibly arrest growth in the normal cells in a way that is very reminiscent of mitomycin-C treatment or radiation-induced 'reproductive cell death', resulting in intact monolayers of non-dividing cells. Although the specific cytostatic mechanism was not explored here, it has been suggested that increased free radical generation through lipid peroxidation may be involved (Begin et al., 1986; 1988) . It has been reported that short-chain FAs may kill colonic tumour cells by inducing apoptosis (Hague et al., 1995) . Using morphological criteria, we did not observe apoptotic cells in normal urothelial cells treated with high concentrations of long-chain (18 -22 carbon) PUFAs. Although further specific studies would be required, these observations suggest that short-chain FAs may have a different mode of action or induce apoptosis specifically in malignantly transformed cells. Alternatively, this may reflect a biological difference between epithelial cells of intestinal and urothelial origins, as there is good evidence that apoptosis is a central mechanism for normal epithelial cell turnover in the intestinal tract (Hall et al., 1994) .
In conclusion, we suggest that normal human epithelial cells show considerable sensitivity to PUFAs that probably relates to proliferation rate in vitro, rather than reflecting any intrinsic differences between epithelial cells and their malignantly transformed carcinoma counterparts.
